maleimide has been researched along with Liver Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carr, BI; Kar, S; Michejda, CJ; Wang, M; Yao, W | 1 |
1 other study(ies) available for maleimide and Liver Neoplasms
Article | Year |
---|---|
PM-20, a novel inhibitor of Cdc25A, induces extracellular signal-regulated kinase 1/2 phosphorylation and inhibits hepatocellular carcinoma growth in vitro and in vivo.
Topics: Animals; Carcinoma, Hepatocellular; cdc25 Phosphatases; Enzyme Activation; Enzyme Inhibitors; Humans; In Vitro Techniques; Liver Neoplasms; Maleimides; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Phosphorylation; Rats; Tumor Cells, Cultured | 2006 |